Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report.

João Vasco Barreira José Leão Mendes Anuraj Quiran Parmanande

Published in: Journal of medical case reports (2023)

Focusing on the reality of ALK positive patients and the impact that this therapy has on the daily lives of our patients, we can contribute to the awareness of this specific pathology.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
physical activity
stem cells
patient reported
smoking cessation
chemotherapy induced